Brendan Kelly

1.2k total citations
25 papers, 875 citations indexed

About

Brendan Kelly is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Brendan Kelly has authored 25 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Organic Chemistry and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Brendan Kelly's work include Receptor Mechanisms and Signaling (9 papers), Neuropeptides and Animal Physiology (8 papers) and Crystallography and molecular interactions (4 papers). Brendan Kelly is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Neuropeptides and Animal Physiology (8 papers) and Crystallography and molecular interactions (4 papers). Brendan Kelly collaborates with scholars based in Ireland, United States and Spain. Brendan Kelly's co-authors include Ron O. Dror, Isabel Rozas, T.C.M. Seegar, Brian J. McMillan, Stephen C. Blacklow, Brandon Zimmerman, Andrew C. Kruse, Robin M. Betz, Fernando Blanco and AJ Venkatakrishnan and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Brendan Kelly

25 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brendan Kelly Ireland 16 591 211 182 91 86 25 875
Hideki Tsujishita Japan 15 587 1.0× 181 0.9× 103 0.6× 86 0.9× 78 0.9× 23 783
Heidi Koldsø Denmark 26 1.3k 2.2× 422 2.0× 122 0.7× 34 0.4× 74 0.9× 40 1.7k
Joel Karpiak United States 13 729 1.2× 330 1.6× 59 0.3× 68 0.7× 224 2.6× 14 991
Rodney A. Bednar United States 20 423 0.7× 128 0.6× 259 1.4× 98 1.1× 19 0.2× 44 1.0k
Agnieszka K. Bronowska United Kingdom 21 913 1.5× 92 0.4× 140 0.8× 100 1.1× 204 2.4× 42 1.5k
Jarrod A. Smith United States 22 1.3k 2.1× 182 0.9× 187 1.0× 17 0.2× 45 0.5× 36 1.7k
Joseph Parello France 21 985 1.7× 293 1.4× 202 1.1× 100 1.1× 26 0.3× 46 1.4k
Michael Sabio United States 20 585 1.0× 206 1.0× 395 2.2× 33 0.4× 135 1.6× 44 1.1k
Margarida Gairí Spain 17 941 1.6× 116 0.5× 111 0.6× 16 0.2× 69 0.8× 33 1.2k
Andy Merritt United Kingdom 15 430 0.7× 95 0.5× 224 1.2× 10 0.1× 172 2.0× 32 816

Countries citing papers authored by Brendan Kelly

Since Specialization
Citations

This map shows the geographic impact of Brendan Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brendan Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brendan Kelly more than expected).

Fields of papers citing papers by Brendan Kelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brendan Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brendan Kelly. The network helps show where Brendan Kelly may publish in the future.

Co-authorship network of co-authors of Brendan Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Brendan Kelly. A scholar is included among the top collaborators of Brendan Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brendan Kelly. Brendan Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kelly, Brendan, Scott A. Hollingsworth, David C. Blakemore, et al.. (2021). Delineating the Ligand–Receptor Interactions That Lead to Biased Signaling at the μ-Opioid Receptor. Journal of Chemical Information and Modeling. 61(7). 3696–3707. 18 indexed citations
3.
Shivnaraine, Rabindra V., Brendan Kelly, Xi‐Ping Huang, et al.. (2021). Allostery of atypical modulators at oligomeric G protein-coupled receptors. Scientific Reports. 11(1). 9265–9265. 1 indexed citations
4.
Kelly, Brendan, Fernando Rodrı́guez, Aintzane García‐Bea, et al.. (2020). Di-aryl guanidinium derivatives: Towards improved α2-Adrenergic affinity and antagonist activity. European Journal of Medicinal Chemistry. 209. 112947–112947. 4 indexed citations
5.
Hollingsworth, Scott A., Brendan Kelly, Céline Valant, et al.. (2019). Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs. Nature Communications. 10(1). 3289–3289. 57 indexed citations
6.
Fertan, Emre, Kurt R. Stover, Brendan Kelly, et al.. (2019). Effects of the Novel IDO Inhibitor DWG-1036 on the Behavior of Male and Female 3xTg-AD Mice. Frontiers in Pharmacology. 10. 1044–1044. 38 indexed citations
7.
McCorvy, John D., Kyle V. Butler, Brendan Kelly, et al.. (2017). Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs. Nature Chemical Biology. 14(2). 126–134. 131 indexed citations
8.
Trujillo, Cristina, Goar Sánchez‐Sanz, Brendan Kelly, et al.. (2017). Thiophene/thiazole-benzene replacement on guanidine derivatives targeting α 2 -Adrenoceptors. European Journal of Medicinal Chemistry. 138. 38–50. 18 indexed citations
9.
Zimmerman, Brandon, Brendan Kelly, Brian J. McMillan, et al.. (2016). Crystal Structure of a Full-Length Human Tetraspanin Reveals a Cholesterol-Binding Pocket. Cell. 167(4). 1041–1051.e11. 210 indexed citations
10.
Shivnaraine, Rabindra V., Yuchong Li, Brendan Kelly, et al.. (2016). Single-Molecule Analysis of the Supramolecular Organization of the M2 Muscarinic Receptor and the Gαi1 Protein. Journal of the American Chemical Society. 138(36). 11583–11598. 19 indexed citations
11.
Diez‐Cecilia, Elena, et al.. (2015). Probing a 3,4′-bis-guanidinium diaryl derivative as an allosteric inhibitor of the Ras pathway. Bioorganic & Medicinal Chemistry Letters. 25(19). 4287–4292. 8 indexed citations
12.
Kelly, Brendan, Carolina Muguruza, Jorge E. Ortega, et al.. (2014). α2-Adrenoceptor Antagonists: Synthesis, Pharmacological Evaluation, and Molecular Modeling Investigation of Pyridinoguanidine, Pyridino-2-aminoimidazoline and Their Derivatives. Journal of Medicinal Chemistry. 58(2). 963–977. 25 indexed citations
13.
Diez‐Cecilia, Elena, Brendan Kelly, Concepción Pérez, et al.. (2014). Guanidinium-based derivatives: Searching for new kinase inhibitors. European Journal of Medicinal Chemistry. 81. 427–441. 21 indexed citations
14.
15.
Kelly, Brendan & Isabel Rozas. (2013). Copper(II) chloride promoted transformation of amines into guanidines and asymmetrical N,N′-disubstituted guanidines. Tetrahedron Letters. 54(30). 3982–3984. 14 indexed citations
16.
O’Donovan, Daniel H., et al.. (2013). A structural study of N,N′-bis-aryl-N′′-acylguanidines. New Journal of Chemistry. 37(8). 2408–2408. 6 indexed citations
17.
Kelly, Brendan, Daniel H. O’Donovan, John E. O’Brien, et al.. (2011). Pyridin-2-yl Guanidine Derivatives: Conformational Control Induced by Intramolecular Hydrogen-Bonding Interactions. The Journal of Organic Chemistry. 76(22). 9216–9227. 21 indexed citations
18.
Blanco, Fernando, Brendan Kelly, Ibón Alkorta, Isabel Rozas, & José Elguero. (2011). Cation–π interactions: Complexes of guanidinium and simple aromatic systems. Chemical Physics Letters. 511(1-3). 129–134. 32 indexed citations
19.
Diez‐Cecilia, Elena, Brendan Kelly, & Isabel Rozas. (2011). One-step double reduction of aryl nitro and carbonyl groups using hydrazine. Tetrahedron Letters. 52(50). 6702–6704. 9 indexed citations
20.
O’Brien, Terrence E., et al.. (2010). Synthesis of aryl-heteroaryl ureas (AHUs) based on 4-aminoquinoline and their evaluation against the insulin-like growth factor receptor (IGF-1R). Bioorganic & Medicinal Chemistry. 18(16). 5995–6005. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideki Tsujishita Breakdown of academic impact, for papers by Heidi Koldsø Breakdown of academic impact, for papers by Joel Karpiak Breakdown of academic impact, for papers by Rodney A. Bednar Breakdown of academic impact, for papers by Agnieszka K. Bronowska Breakdown of academic impact, for papers by Jarrod A. Smith Breakdown of academic impact, for papers by Joseph Parello Breakdown of academic impact, for papers by Michael Sabio Breakdown of academic impact, for papers by Margarida Gairí Breakdown of academic impact, for papers by Andy Merritt
Rankless by CCL
2026